Surgical Science Sweden AB (publ) (STO: SUS)
122.30
-1.70 (-1.37%)
Sep 2, 2024, 10:41 AM CET
SUS Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 667.08 | 634.37 | 433.73 | 316.68 | 87.16 | 69.22 | Upgrade
|
Cash & Short-Term Investments | 667.08 | 634.37 | 433.73 | 316.68 | 87.16 | 69.22 | Upgrade
|
Cash Growth | 16.13% | 46.26% | 36.96% | 263.34% | 25.92% | 79.80% | Upgrade
|
Accounts Receivable | 96.25 | 110.6 | 176.31 | 110.65 | 18.59 | 17.07 | Upgrade
|
Other Receivables | 30.06 | 81.11 | 67.81 | 69.14 | 13.48 | 15.4 | Upgrade
|
Receivables | 126.31 | 191.71 | 244.13 | 179.79 | 32.07 | 32.47 | Upgrade
|
Inventory | 177.77 | 154.45 | 134.88 | 113.11 | 12.46 | 7.19 | Upgrade
|
Prepaid Expenses | 92.28 | 10.67 | 13.63 | 7.33 | 1.7 | 3.9 | Upgrade
|
Total Current Assets | 1,063 | 991.19 | 826.37 | 616.91 | 133.39 | 112.77 | Upgrade
|
Property, Plant & Equipment | 75.43 | 76.62 | 51.36 | 38.39 | 8.55 | 9.07 | Upgrade
|
Goodwill | 3,503 | 3,329 | 3,444 | 3,019 | 260.49 | 260.49 | Upgrade
|
Other Intangible Assets | 300.99 | 286.57 | 301.02 | 274.03 | 62.9 | 66.7 | Upgrade
|
Long-Term Deferred Tax Assets | 15.56 | 14.84 | 22.16 | 24.6 | 6.72 | 6.97 | Upgrade
|
Other Long-Term Assets | 5.01 | 4.77 | 4.37 | 4.97 | 0.21 | 0.21 | Upgrade
|
Total Assets | 4,963 | 4,703 | 4,650 | 3,978 | 472.27 | 456.21 | Upgrade
|
Accounts Payable | - | 41.29 | 65.69 | 34.37 | 2.3 | 2.37 | Upgrade
|
Accrued Expenses | - | 47.34 | 44.27 | 104.18 | 9.87 | 10.22 | Upgrade
|
Current Income Taxes Payable | - | 31.03 | 13.9 | 5.49 | 6.66 | 12.41 | Upgrade
|
Current Unearned Revenue | - | 72.89 | 70.65 | 16.95 | 4.94 | 4.04 | Upgrade
|
Other Current Liabilities | 256.33 | 42.39 | 111.4 | 71.39 | 7.51 | 10.54 | Upgrade
|
Total Current Liabilities | 256.33 | 234.94 | 305.91 | 232.38 | 31.28 | 39.58 | Upgrade
|
Long-Term Leases | - | 40.02 | 14.68 | 12.07 | 2.32 | 2.25 | Upgrade
|
Long-Term Unearned Revenue | - | 20.29 | 27.62 | 20.49 | - | - | Upgrade
|
Long-Term Deferred Tax Liabilities | - | 45 | 51.51 | 48.51 | 9.66 | 9.42 | Upgrade
|
Other Long-Term Liabilities | 113.4 | 17.21 | 13.4 | 79.61 | 1.97 | 3.29 | Upgrade
|
Total Liabilities | 369.72 | 357.46 | 413.11 | 393.06 | 45.22 | 54.54 | Upgrade
|
Common Stock | 2.55 | 2.55 | 2.54 | 2.54 | 1.73 | 1.68 | Upgrade
|
Additional Paid-In Capital | 3,398 | 3,398 | 3,379 | 3,379 | 425.62 | 416.32 | Upgrade
|
Retained Earnings | 560.12 | 507.76 | 273.79 | 85.82 | -0.43 | -16.04 | Upgrade
|
Comprensive Income & Other | 632.46 | 436.78 | 581.14 | 117.73 | 0.14 | -0.29 | Upgrade
|
Shareholders' Equity | 4,593 | 4,345 | 4,236 | 3,585 | 427.05 | 401.68 | Upgrade
|
Total Liabilities & Equity | 4,963 | 4,703 | 4,650 | 3,978 | 472.27 | 456.21 | Upgrade
|
Total Debt | - | 40.02 | 14.68 | 12.07 | 2.32 | 2.25 | Upgrade
|
Net Cash (Debt) | 667.08 | 594.34 | 419.05 | 304.61 | 84.84 | 66.97 | Upgrade
|
Net Cash Growth | 16.13% | 41.83% | 37.57% | 259.05% | 26.68% | 73.96% | Upgrade
|
Net Cash Per Share | 13.07 | 11.67 | 8.23 | 7.14 | 2.47 | 2.31 | Upgrade
|
Filing Date Shares Outstanding | 51.03 | 51.03 | 50.8 | 50.8 | 34.49 | 33.62 | Upgrade
|
Total Common Shares Outstanding | 51.03 | 51.03 | 50.8 | 50.8 | 34.49 | 33.62 | Upgrade
|
Working Capital | 807.1 | 756.26 | 520.46 | 384.53 | 102.12 | 73.19 | Upgrade
|
Book Value Per Share | 90.02 | 85.16 | 83.39 | 70.57 | 12.38 | 11.95 | Upgrade
|
Tangible Book Value | 789.7 | 729.96 | 491.14 | 291.81 | 103.65 | 74.49 | Upgrade
|
Tangible Book Value Per Share | 15.48 | 14.31 | 9.67 | 5.74 | 3.00 | 2.22 | Upgrade
|
Machinery | - | 132.67 | 91.23 | 58.54 | 16.19 | 15.1 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.